Projects per year
Fingerprint
Dive into the research topics where Robert B Diasio is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
CANCER AND LEUKEMIA GROUP B
National Cancer Institute, National Institutes of Health
Project: Research project
-
-
-
-
Research output
-
Haplotype structure defines effects of common DPYD variants c.85T > C (rs1801265) and c.496A > G (rs2297595) on dihydropyrimidine dehydrogenase activity: Implication for 5-fluorouracil toxicity
Hamzic, S., Schärer, D., Offer, S. M., Meulendijks, D., Nakas, C., Diasio, R. B., Fontana, S., Wehrli, M., Schürch, S., Amstutz, U. & Largiadèr, C. R., Aug 2021, In: British Journal of Clinical Pharmacology. 87, 8, p. 3234-3243 10 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Pharmacogenomic-Guided Therapy in Colorectal Cancer
Diasio, R. B., Innocenti, F. & Offer, S. M., Sep 2021, In: Clinical pharmacology and therapeutics. 110, 3, p. 616-625 10 p.Research output: Contribution to journal › Review article › peer-review
-
A novel nomenclature for repeat motifs in the thymidylate synthase enhancer region and its relevance for pharmacogenetic studies
Schaerer, D., Froehlich, T. K., Hamzic, S., Offer, S. M., Diasio, R. B., Joerger, M., Amstutz, U. & Largiadèr, C. R., Dec 2020, In: Journal of Personalized Medicine. 10, 4, p. 1-13 13 p., 181.Research output: Contribution to journal › Article › peer-review
Open Access -
Intergroup Randomized Phase III Study of Postoperative Oxaliplatin, 5-Fluorouracil, and Leucovorin Versus Oxaliplatin, 5-Fluorouracil, Leucovorin, and Bevacizumab for Patients with Stage II or III Rectal Cancer Receiving Preoperative Chemoradiation: A Trial of the ECOG-ACRIN Research Group (E5204)
Chakravarthy, A. B., Zhao, F., Meropol, N. J., Flynn, P. J., Wagner, L. I., Sloan, J., Diasio, R. B., Mitchell, E. P., Catalano, P., Giantonio, B. J., Catalano, R. B., Haller, D. G., Awan, R. A., Mulcahy, M. F., O'Brien, T. E., Santala, R., Cripps, C., Weis, J. R., Atkins, J. N., Leichman, C. G. & 9 others, , May 1 2020, In: Oncologist. 25, 5, p. e798-e807Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Severe capecitabine toxicity associated with a rare DPYD variant identified through whole-genome sequencing
Ly, R. C., Schmidt, R. E., Kiel, P. J., Pratt, V. M., Schneider, B. P., Radovich, M., Offer, S. M., Diasio, R. B. & Skaar, T. C., 2020, In: JCO Precision Oncology. 4, p. 632-638 7 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations